FDX1 and nonpapillary renal cell carcinoma: Furthermore, a luciferase activity assay indicated a negative correlation between miR-21-5p and FDX1, suggesting that miR-21-5p acts as an upstream regulator of FDX1 in driving ccRCC development (Xie et al., 2022).